Respreeza® Self-administration and Learning Program (AmAREtTI Study)

Clinical trial NCT04262284 · COMPLETED

Trial details

NCT number: NCT04262284
Sponsor: CSL Behring
Status: COMPLETED
Study type: OBSERVATIONAL

Alpha-1 Antitrypsin Deficiency

Start date: 2019-10-18
Primary completion: 2024-05-06
Enrollment: 15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.